Significant research findings on cardiovascular comorbidities, innovative treatment strategies with ravulizumab, management approaches for flares, and holistic self-care practices in myasthenia gravis.
Complexities of immune checkpoint inhibitors in cancer therapy, the role of AI in personalizing Myasthenia Gravis treatment, and the ongoing community efforts to advance treatment options.
Promising treatments for mysathenia gravis, ongoing advocacy for medication approval, and inspiring patient stories of resilience.